Antitrust Concerns Don’t Cloud Merck-Schering Deal
Executive Summary
Merck and Schering Plough may not have to shed many compounds to get the Federal Trade Commission to approve their merger as there appears to be very little product overlap
You may also be interested in...
Schering Helps Merck Where It’s Needed Most: The Pipeline
Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity
Schering Helps Merck Where It’s Needed Most: The Pipeline
Bulking up the pipeline is a frequent motive for a pharmaceutical merger - but somewhat unusual for Merck, a company that has long prided itself on the strength of its R&D activity
Antitrust Enforcement Under Obama: Pfizer-Wyeth Offers An Early Test
President Obama pledged to reinvigorate antitrust enforcement during his campaign for the Oval Office. Pfizer's proposed acquisition of Wyeth gives the administration an early opportunity to test that promise